今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1821次   下载 1988 本文二维码信息
码上扫一扫!
分享到: 微信 更多
清肺通络方对小儿支原体肺炎细胞因子的干预及疗效观察
姜永红1, 姜之炎1, 叶飞2, 吴文2, 李文2, 郭爱华2, 徐彬彬2, 马晶2, 张婧延2, 胡鹏2, 石李2
1.上海中医药大学附属龙华医院儿科, 上海, 200032上海中医药大学, 上海市中医药研究院中医儿科研究所, 上海, 200071;2.上海中医药大学附属龙华医院儿科, 上海, 200032
摘要:
[目的]观察清肺通络方对小儿支原体肺炎(MP)的疗效及对血清干扰素-γ(IFN-γ)、白介素-4(IL-4)、白介素-17(IL-17)的影响。[方法]选取支原体肺炎患儿135例,随机分为对照组和治疗组,观察两组的疗效,治疗前后血清IFN-γI、L-4I、L-17的变化。[结果]治疗组总有效率为94.67%,明显高于单纯西药对照组(P<0.05)。肺炎支原体肺炎患儿较正常儿童血清IFN-γI、L-4I、L-17均升高I,L-4I、L-17的差异有统计学意义(P<0.01,)IFN-γ升高无统计学意义。治疗组治疗前后血清IL-4I、L-17含量显著降低(P<0.01)I,FN-γ降低无统计学意义;对照组治疗前后差异无统计学意义。[结论]清肺通络方联合阿奇霉素治疗MPP疗效可靠,其机制可能与调节免疫紊乱有关。
关键词:  清肺通络方  支原体肺炎  细胞因子  疗效
DOI:10.11656/j.issn.1672-1519.2011.04.07
分类号:
基金项目:上海中医药大学科研发展基金资助项目(0935)
Study on therapeutic and intervention effect of Qingfeitongluo prescription on cytokines in patients with MP
JIANG Yong-hong1, JIANG Zhi-yan1, Ye Fei2
1.Pediatric Department, Longhua Hospital Affiliated to Shanghai University of TCM, Shanghai 200032, ChinaShanghai University of TCM /Pediatric Institute of Shanghai TCM Academy, Shanghai 200071, China;2.Pediatric Department, Longhua Hospital Affiliated to Shanghai University of TCM, Shanghai 200032, China
Abstract:
[Objective] To observe the intervention and therapeutic effect of Qingfeitongluo prescription on serum IFN-γ,IL-4,IL-17 levels in patients with mycoplasma pneumonia(MP).[Methods] 135 cases with MP children were randomly divided into control group and treatment group.The therapeutic effects were observed in these two groups and the changes of serum levels of IFN-γ,IL-4,IL-17 before and after treatment were determined.[Results] The total effective rate of the treatment group was 94.67%,which was significantly higher than the control group(P<0.05).Serum IFN-γ,IL-4,IL-17 levels were increased in MP children compared with normal children with significant difference in IL-4 and IL-17(P<0.01),with no difference in IFN-γ level.After treatment serum IFN-γ,IL-4,IL-17 levels were decreased in both groups without significant difference when compared with control group,while in the treatment group,serum IL-4,IL-17 levels were significantly decreased(P<0.01) and decreasing trend in IFN-γ was noted but no significant difference could be seen.[Conclusion] Qingfeitongluo prescription combined with azithromycin to treat MPP had reliable efficacy,which may be related with the regulation of immune disorders.
Key words:  Qingfeitongluo prescription  mycoplasma pneumonia(MP)  cytokines  therapeutic effect
关注公众号二维码